Zacks Small Cap Research on MSN5 天
FBLG: On Target to Initiate Phase 1/2 Trial in 2025…
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers FibroBiologics, Inc. (NASDAQ:FBLG) is on track to initiate a Phase 1/2 trial of ...